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Abstract 
 
Introduction 
Pain tolerance has been identified as a potential factor attributable to an athlete’s 
success. Previous studies have reported that high intensity intermittent training 
(HIIT) can increase pain tolerance and exercise capacity. However, it is unclear if 
short HIIT programs are effective at increasing pain tolerance and self-paced 
exercise performance. Consequently, we investigated the effect of a short HIIT 
intervention on pain tolerance and 5 km time trial (TT) cycling performance. 
 
Methods 
Participants (n=18) were randomly assigned and completed either three (Ex-1; n=9) 
or six HIIT sessions (Ex-2; n=9). HIIT involved participants cycling at RPE=15 
(6x5mins interspersed by 1mins recovery). Participant’s pain catastrophizing (PCS), 
anxiety (PASS-20), ischemic pain tolerance test and 5 km TT performance 
responses were assessed at baseline and three or six HIIT sessions  
 
Results 
No changes in power output, heart rate or RPE were observed across subsequent 
HIIT sessions. Pain tolerance and threshold remained unchanged after HIIT. 
Participant’s PASS responses remained unchanged after HIIT but PCS responses 
did decrease following HIIT (p=0.002, d=0.56) with no difference between groups. 5 
km TT performance remained unchanged although HR decreased after HIIT with no 
difference between groups (p=0.031, d=0.27).  
 
Conclusion 
Self-paced HIIT was ineffective at increase pain tolerance and cycling time trial 
performance. This is likely due to the current protocols inefficiency to get 
participants to exercise to their tolerance and not eliciting the necessary metabolic 
demands to promote aerobic physiological adaptations respectively. Therefore, 
future research should consider this and design self-paced HIIT protocols that do 
not compromise training intensity. Furthermore, research focusing on other 
psychological measures (e.g. self-efficacy and pain management strategies) should 
also be considered when assessing the effect of any exercise training on pain 
tolerance to better understand why any changes in pain tolerance occur. 
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1 Introduction: 
1.1 What is Pain? 
 
From the beginning of our lives we are taught that pain serves as a warning signal 
that something is wrong. It is even capable of facilitating recovery in patients by 
allowing them to avoid touching a certain injury or performing certain actions that 
may result in further damage. In this sense pain can be considered as a protective 
mechanism. 
 
The International Association for the Study of Pain (IASP, 2012) define pain as “An 
unpleasant sensory and emotional experience associated with actual; or potential 
tissue damage or described in terms of such damage”. By this definition pain is 
always a subjective experience and should be interpreted as such. Furthermore, 
this definition also recognizes that pain can sometimes arise from psychological 
reasons in the absence of any apparent tissue damage or any pathophysiological 
cause. For example, most patients with an amputation often experience phantom 
limb pain whereby they feel pain in their amputated or missing limb (Andoh et al., 
2017). The importance of this is that the perception of pain can never always be 
associated with observable tissue damage and psychological influences should 
always be considered. 
 
Pain is often classified into two broad categories which are important to distinguish; 
neuropathic and nociceptive pain. Neuropathic pain affects an estimated 6.9 - 10% 
of the general population and is a clinical description rather than a diagnosis (Van 
Hecke et al., 2014). For example, a recent health survey within a US population, 
conducted by DiBonaventura et al (2017), observed a prevalence rate for 
neuropathic pain of 10% (95% CI 9.5% - 10.6%). that It describes pain that is 
caused by a lesion or disease of the somatosensory nervous system. In contrast, 
nociceptive pain can be defined as “pain that arises from actual or threatened 
damage to non-neural tissue” and often occurs with a normally functioning 
somatosensory nervous system (O’Connor and Cook, 1999). In this regard 
nociception describes the neural process of interpreting and encoding noxious 
stimuli. The process of nociception is an extremely complicated process and a 
complete description would not be in scope of this project. Nevertheless, it is 
important to understand the mechanisms involved and a brief overview is provided 
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in section 2.1. For a more detailed overview the reader is directed to a paper 
reviews conducted by O’Connor and Cook. (1999) and Light et al. (2008).  
 
Two common variables measured when assessing a person’s pain response are 
pain threshold and tolerance. These two variables are not one in the same despite 
being used interchangeably among the general population. For this work pain 
threshold represents the minimum intensity of a noxious stimulus to be perceived as 
painful (IASP, 2017). Conversely, pain tolerance will be defined simply as maximum 
intensity of a noxious stimulus an individual is willing to accept (i.e. tolerate; IASP, 
2017).  
1.2 Exercise Induced Pain and Effect of Training on Pain Perception 
 
Pain arising from exercise can be referred to as exercise induced pain and is often 
termed with the denotation “EIP”. Briefly, it is primarily caused as exercise itself 
results in an increase in muscle distortions, noxious metabolites and intramuscular 
pressure which activate various muscle nociceptors (O’Connor and Cook, 1999; 
Stevens et al., 2017). Afferent feedback from muscle nociceptors, especially type 
III/IV nociceptors is then received and interpreted by structures associated with the 
pain matrix. This not only causes the sensation of pain to occur but also limits the 
development of further locomotor muscle fatigue by altering central motor drive to 
exercising muscles to maintain homeostasis (Amann, 2012). This localised 
perception of pain in the primary exercising muscles with time will eventually spread 
to other locations such as the chest at the end of exhaustive running (Slapsinskaite 
et al., 2015). 
 
Exercise induced pain itself has been demonstrated to be directly correlated with 
exercise intensity and duration in a series of studies conducted by Cook et al. 
(1997). As acknowledged by Stevens et al. (2017), it is also clear that EIP is 
important for self-paced exercise. Evidence for this comes from methods designed 
to inhibit pain mechanisms (Mauger et al., 2010; Foster et al., 2014; Delextrat et al., 
2015; Astokorki and Mauger, 2017) as well as observational studies of athletes 
during competition (Whitehead et al., 2017).  
 
It should be recognized that EIP is a different construct from perceived exertion. 
Perceived exertion during exercise is often measured as “rating of perceived 
exertion” using the 6-20 Borg scale (RPE). The RPE scale was originally designed 
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by Gunnar Borg (1970) with the intention of matching heart rates ranging from 60-
200bpm (Borg et al., 1982) and has been widely used since. A study conducted by 
Astokorki and Mauger (2017) observed that after transcutaneous electrical nerve 
stimulation (TENS) EIP decreased, whilst RPE did not change, during a time to 
exhaustion (12% mean reduction). Consequently, exertion and pain should be 
treated as separate entities. 
 
Exercise induced pain experienced during training may also be responsible for 
increasing pain tolerance. This is supported by evidence from a systematic review 
of cross sectional studies conducted by Tesarz et al. (2012), aerobic training 
(Anshel and Russell, 1994; Jones et al., 2014; O’Leary et al., 2017a) and 
longitudinal studies (Scott and Gijsbers, 1981; Thornton et al., 2017) which report 
higher pain tolerances in athletes and after periods of training respectively.  
 
Specifically, a recent study conducted by O’Leary et al. (2017a) observed that high 
intensity intermittent training was more effective than a traditional continuous 
training program at increasing pain tolerance and exercise capacity. The authors 
attribute this difference largely due to HIIT causing greater consistent and frequent 
exposure to unpleasant sensory experiences. This is supported by “within-training” 
data (O’Leary et al., 2017b) which demonstrates that whilst participants consistently 
reported RPE ratings of 19-20 during the last 5min of each HIIT sessions those in 
the CONT never reported an RPE above 15. Whilst the mechanisms for these 
observations are still unclear (Stevens et al., 2017), reductions in inhibitory 
feedback from muscle afferents (Amann et al., 2015) and alterations in 
psychological variables such as pain specific; anxiety, catastrophizing and self-
efficacy have been previously attributed for increases in pain tolerance following 
periods of aerobic training (Jones et al., 2014; O’Leary et al., 2017a) and for 
explaining the differences in pain tolerance between athletes and non-athletes 
(Roebuck et al., 2018; Thornton et al., 2017; Geva and Defrin, 2013; Johnson et al., 
2011; Sullivan, 2000). Furthermore, it is uncertain whether shorter HIIT programs 
would be as effective at increasing pain tolerance. 
1.3 What is High-intensity Interval Training? 
 
The nomenclature proposed by Weston et al. (2014) put forward the idea that 
interval training can be defined as either high intensity intermittent training (HIIT) or 
sprint interval training (SIT). Despite there being no universal definition for HIIT it is 
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generally accepted among the scientific community that HIIT refers to repeated 
sessions of intermittent exercise often performed at an intensity above a steady 
state approximately 80–95% HRmax (MacInnis and Gibala, 2017). On the other 
hand, SIT refers to brief all out or supramaximal cycling efforts (often at or above 
intensities that would elicit VO2max). 
 
The most well-studied SIT protocol is a Wingate type test (Gibala and McGee, 
2008) which involves intermittent (6-30s) all out cycling efforts against a resistance 
equivalent to ~7.5% of the participants body weight interspersed by periods of 
recovery (Bar-Or et al., 1987). Not only has this approach been shown to be reliable 
and valid but studies have demonstrated an increase physiological markers and 
exercise performance after just six SIT sessions (Burgomaster et al., 2005; 
Burgomaster et al., 2006; Gibala et al., 2006). However, SIT protocols require an 
extremely high level of physical exertion from the participant. Consequently, it is not 
uncommon for side effects such as nausea, vomiting and fainting to ensue if they 
are untrained and do not perform an appropriate warm-up/cooldown (Suroweic et 
al., 2014). In contrast, HIIT has been shown to be just as effective as SIT at eliciting 
similar physiological adaptations and enhancing exercise performance across 
similar time periods (MacInnis et al., 2017) with fewer negative side effects. 
 
Consequently, we investigated the impact of short HIIT interventions on ischemic 
pain tolerance. Moreover, we also sought to determine the effect of HIIT on self-
paced exercise performance rather than exercise capacity as the former has more 
external validity to endurance performance. Furthermore, we also investigated the 
impact HIIT had on pain catastrophizing and anxiety. This was to determine whether 
changes in psychology could be affected by HIIT and if these changes could explain 
variances in any of the observed outcome measures most noticeably pain tolerance 
and/or self-paced exercise performance. 
 
2.0 Literature Review: 
 
In sporting performance, when time to completion is the outcome measure, fatigue 
is the ultimate determining factor of success (Mauger, 2013). In this sense fatigue 
can be defined as an exercise-induced reduction in the athlete’s ability to produce 
muscle force/power regardless of if the task can be sustained (Mauger, 2013). 
Whilst previous explanations have considered fatigue from a peripheral perspective 
(Kent-Braun, 1999) this comes from studies employing task to failure/time to 
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exhaustion methods. The problem is that almost all sports do not end in task failure 
and are instead largely self-paced. Therefore, the mechanisms which govern fatigue 
in task failure and work rate regulation are not necessarily synonymous (Mauger et 
al., 2013). Instead Noakes (2012) theory of central control suggests that, in 
conjunction with past experiences and current knowledge, afferent feedback from 
the periphery is collected and processed to produce the sensation of “fatigue”. One 
variable of considerable interest is pain experienced during exercise (EIP) as 
feedback from muscle nociceptors has been previously associated with central 
fatigue in the exercising muscles (Amann et al, 2012; see section 2.1 for greater 
detail). 
 
Previous investigations have demonstrated that as exercise intensity and/or 
duration increases so does the amount of EIP an athlete experiences (Cook et al., 
1997; Ljunggren et al., 1987). For example, in a series of experiments conducted by 
Cook et al. (1997) it was reported that as cycling exercise intensity increases so 
does EIP originating from the leg muscles. In one of their experiments male subjects 
(n=11) completed a maximal cycle ergometer test starting at power output of 50 W 
and continually increasing by 24 W per minute. During the test pain ratings (0-10) 
were obtained every minute until pain threshold. At this point leg muscle pain ratings 
were then obtained every 30 s until volitional exhaustion. Results demonstrated that 
leg muscle pain increased relative to peak power output and VO2max. Similarly, in a 
separate experiment exercise intensity was also positively correlated with leg 
muscle pain, measured via a visual analogue scale (r=0.79-0.94). 
 
Feedback from type III and IV muscle afferents, which are initially responsible for 
the neural processing of pain, has also been demonstrated to impact exercise 
performance (Amann, 2012). This was first observed during studies that measured 
the maximal isometric exercise performance of a single muscle (Amann, 2012). For 
instance, when central projection of type III/IV muscle afferents is maintained after a 
2 min maximal voluntary contraction of the biceps brachii (via inflating a 
sphygmometer to 300 mmHg to induce ischaemia thereby blocking off blood supply 
to the brachioradialalis), then central motor neural drive and voluntary muscle 
activation persist at low levels and do not recover until circulation, and thus firing 
frequency of the type III/IV muscle afferents, is restored (Gandevia, 1998).  These 
findings were expanded upon by Amann (2008) who observed that blocking 
feedback from type III/IV muscle afferents, via lumbar intrathecal fentanyl, 
attenuated the inhibitory effect of these nociceptors resulting in an increased (less 
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restricted) central motor neural drive. Indeed, during the experimental condition (i.e. 
blocked afferent feedback) the power output of participants during the first 2.5 km 
was substantially higher than during the placebo 5 km time trial (i.e. intact afferent 
feedback). Taken together these studies suggest that type III/IV muscle afferents 
are responsible for providing feedback to the central nervous system (CNS) which 
itself exerts a negative influence on the central motor neural drive to the locomotor 
muscles (Amann, 2012). This is most to occur to prevent the development of 
excessive peripheral fatigue and thus harm to the organism (Amann, 2012). 
 
In a similar experiment Amann et al. (2010) also demonstrated that when feedback 
from type III/IV muscle afferents was blocked, via lumbar intrathecal fentanyl, that; 
minute ventilation (L/min), arterial haemoglobin saturation and breathing frequency 
were compromised during cycling exercise performed at various workloads (50 to 
325 W). This suggests that afferent feedback from locomotor muscles is also 
important during whole body exercise performance as it prevents premature fatigue 
by allowing the appropriate ventilatory and circulatory responses to occur.  
 
In summary pain and exercise are closely interlinked. Not only does pain increase 
with exercise intensity and duration but afferent feedback from muscle nociceptors, 
that are themselves responsible for the neural processing of pain (see section 2.1), 
impact exercise performance by adjusting central motor neural drive to locomotor 
muscles as well as influence the ventilation and cardiovascular responses so that 
excessive exhaustion and thus harm to the organism is prevented. 
 
2.1 Neurobiology of Pain and EIP 
 
Type III and IV receptors, also known as type Aδ and C receptors respectively, 
(Mense and Gerwin, 2010), are responsible for transducing and encoding stimuli 
that have the potential to cause tissue damage (noxious stimuli) as electrical signals 
across the central nervous system (CNS). Whilst similar, the axons of these 
receptors have notable differences. For instance, whilst the axons of Aδ receptors 
are thinly myelinated allowing for a fast conduction velocity (2-25 m/s) the axons of 
type C receptors are not resulting in a slower conduction velocity (<2 m/s) (Mense 
and Gerwin, 2010). However, these receptors also share similarities in that their 
peripheral terminals (free nerve endings) can all be found in the; skin, muscles, 
joints, bone, tendon, intervertebral discs, periosteum and fascia.  
 
12 
 
Furthermore, nociceptors originating from different tissues are often activated by 
different noxious stimuli. For example, cutting the skin would be enough to activate 
cutaneous receptors whilst cutting the viscera does not necessarily activate visceral 
receptors (Mense and Gerwin, 2010). This is important as although multiple tests 
can be used to examine a pain response the mechanisms causing this response are 
not necessarily synonymous across tests. For example, the cold pressor test (CPT) 
causes an algesic response by activating nociceptors located on the skin. In 
contrast, grip contractions performed under ischemic conditions cause a build-up of 
metabolites which activate deep type C nociceptors located primarily in the muscles 
and joints (O’Connor and Cook, 1999). The exact mechanisms underlying the pain 
response during ischemic conditions continue to be determined but may include; 
reductions in muscle pH as well as increased ATP and nonapeptide bradykinin 
(BKN) concentration in the blood (Mense and Gerwin, 2010).  
 
During dynamic exercise the concentration of noxious chemicals, amount of 
mechanical pressure and metabolic disturbance either directly stimulate or sensitize 
type III and IV nociceptors located primarily in the muscle and joints (Pickar et al., 
1994; Adreani et al., 1997; Light et al., 2008). Most of these noxious stimuli are 
summarised in a review paper published by O’Connor and Cook (1999; see table 1).  
 
During exercise the nonapeptide BKN is a potent nociceptive stimulus (Mense and 
Gerwin, 2010). BKN is produced in response to tissue damage and other common 
homeostatic disturbances that occur during exercise such as increased metabolic 
acidosis and hypoxia (Langberg et al., 2002; O’Connor and Cook, 1999). 
Furthermore, it is capable of not only directly activating and sensitizing Aδ and C 
nociceptors but is also responsible for the synthesis and release of potent 
prostaglandins (e.g PGE2). Prostaglandins themselves are significant tuning 
chemicals that are correlated with increased muscular pain and decreased pain 
threshold (Hedenberg-Magnusson et al., 2001). Finally, BKN has also been 
previously demonstrated to be a regulator of blood flow by causing vasodilation 
(Wilson and Kapoor, 1993; Langberg et al., 2002) and thus promote the action of 
other vaso-neuroactive algesics. 
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Substance Primary effect on afferent fibres 
Bradykinin Activation* 
Histamine Activation* 
Potassium Activation* 
Serotonin Activation* 
  
Leukotrienes Sensitization 
Hydrogen ions Sensitization 
Hypoxia Sensitization 
Substance P Sensitization 
Table 1: An adapted table from O’Connor and Cook (Page 122, Table 5.1, O’Connor and Cook; 1999). * = 
Activation of type IV and sensitization of type III afferent fibres.  
 
High intensity exercise also causes the accumulation of hydrogen ions/protons (H+) 
and adenosine triphosphate (ATP). At rest ATP is already at high concentrations in 
the muscle and is required for muscular contraction. During high intensity exercise 
ATP molecules are released from the muscle cells as trauma and/or inflammation 
causes significant damage to the cellular membrane (Mense and Gerwin, 2010). 
Once released, ATP molecules bind to purinergic membrane receptor P2X3 which 
opens an ion channel increasing the permeability to small cations such as Na+ 
(Cook and McCleskey, 2002). Additionally, small increases in the H+ ion 
concentration are known to sufficiently stimulate type IV muscle receptors by 
binding to local acid-sensing ion channels (ASIC1 and 3). Indeed these protein 
channels are sensitive enough to detect small pH changes, for example pH 7.4 to 
7.1 (Mense and Gerwin, 2010). The vanilloid receptor TRPV1 also responds to 
increasing H+ ion concentration as a tissue pH of 6.3 will allow this nociceptor’s 
activation threshold for temperature to decrease from 39ºC to 26ºC (Mense and 
Gerwin, 2010). 
 
Whilst previous studies have demonstrated that individual injection of metabolites 
can produce a pain (Sluka et al., 2001; Mørk et al., 2003; Pollak et al., 2014) the 
evidence is not consistent and typically in isolation these metabolites only cause a 
algesic response when administered at exceedingly high concentrations (Reinohl et 
al., 2003; Hanna and Kaufman, 2004; Light et al., 2008; Pollak et al., 2014). Rather, 
a combination of them are required to evoke a muscular pain response in both 
animals (Light et al., 2008) and humans (Pollak et al., 2014). 
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Specifically, Pollak et al. (2014) reported that increasing concentrations of lactate, 
ATP and H+ in a metabolite solution increased the pain response as measured on a 
visual analogue pain scale (VAS) and through various pain adjectives including 
sensations of aching and hot at the site of injection; the base of the thumb. Indeed, 
at concentrations similar to vigorous exercise, all subjects (n=10) reported more and 
stronger sensations of pain. Consequently, this provides evidence that higher levels 
of noxious stimuli, as produced in HIIT, cause a markedly greater algesic response.  
However, some subjects reported sensations relating to mechanical movement 
including; pressure (n=8), flowing (n=1), vibration (n=1) and heavy (n=3) despite the 
absence of a mechanical stimulus (Pollak et al., 2014). This suggests that the 
metabolites are somewhat capable of activating mechanoreceptive neurons. F 
 
However, as the authors were “unsure of the potential intensity of the evoked 
sensations” metabolite solutions were administered in ascending series. 
Consequently, subjects were not randomized or blinded to solution infusion which 
should be considered a major limitation. Additionally, the site of injection’s muscle is 
highly vascular and neurologically innervated (Pollak et al., 2014). Therefore, the 
activation characteristics for sensations of fatigue/pain for other skeletal muscles 
are likely different. Together, these limitations mean the results should be 
interpreted with caution. 
 
Once a sufficient combination of noxious stimuli are present, type III and IV 
receptors are activated and sensitized, increasing the spontaneous discharge of the 
nociceptors from the periphery to the lumbar dorsal horn of the spinal cord (Amann, 
2012). Here the nociceptive and non-nociceptive afferents converge and release 
both amino acid and peptide-based neurotransmitters that propagate the impulse 
from the spinal cord along ascending pathways (spinothalamic, spinoreticular and 
spinomesencephalic) to various brains structures (O’Connor and Cook, 1999).  
 
Studies measuring regional cerebral blood flow (rCBF) have observed that the 
insular cortex is important at processing pain in isolation (Casey, 1999) and when 
induced by exercise (Williamson et a, 1997).  Other cortical and subcortical areas 
have also been identified to respond to the presentation of a noxious stimulus and 
include the; the bilateral thalamus, secondary somatosensory cortex (SII), premotor 
cortex, anterior cingulate cortex and cerebellar vermis (Casey, 1999; Peyron et al., 
2000; Friebel et al., 2011; Cauda et al., 2014). Together these areas are referred to 
as the “pain matrix”, “neuromatrix” or “salience matrix” and are responsible for the 
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sensory processing of pain among other functionalities (Iannetti and Mouraux, 
2010). However, this evidence largely comes from innocuous stimuli such as 
electrical stimulation and temporal summation. Therefore, caution should be applied 
when interpreting and applying these results to an exercise setting. In contrast, 
studies employing methods, such as hypertonic saline injection and ischaemia, 
should be considered to have greater construct validity as these produce conditions 
which are more representative of the etiology of exercise  
 
Nevertheless, exercise-induced or not, pain perception is a complex process being 
interpreted at various brain structures and not just at a singular site (Cassey, 1999). 
Adding to its complexity, pain can also occur in the absence of any tissue damage 
or obvious pathophysiological cause (Nikolajsen and Jensen, 2006). For example, 
Andoh et al. (2017) reported that patients suffering from phantom limb pain 
exhibited increased activation of the SI, SII and intraparietal sulci (IPS). Additionally, 
the anticipation of pain alone is also associated with pain processing (Porro et al., 
2002) and actual clinical pain experienced by fibromyalgia and osteoarthritis 
patients (Brown et al., 2014). These findings are important as they demonstrate that 
psychological factors should always be considered as a potential algesic/analgesic 
influence independent of any observable tissue damage. 
 
2.2 Exercise Induced Hypoalgesia (EIH) and Athletes vs Non-Athletes 
 
A term that is often referenced in literature, whereby exercise alters pain perception, 
is exercise induced hyperalgesia or EIH. Studies often measure EIH by comparing 
differences in pain threshold before and after exercise (Nauger et al., 2012). EIH is 
well documented following aerobic, isometric and dynamic resistance-based 
exercise in healthy individuals (Nauger et al., 2012; Nauger et al., 2016). 
 
Specifically, aerobic exercise has been demonstrated to produce moderate to large 
EIH as measured by adjusted effect sizes. Indeed, a meta-analytic review by 
Naugle et al. (2012) reported moderate effect sizes when regarding the hypoalgesic 
effects of aerobic exercise in relation to pain threshold (d=0.68) and pain intensity 
(d=0.64). Furthermore, Naugle et al. (2012) also reported a dose-response 
relationship when regarding EIH in that high intensity (>75%VO2max) and longer 
(>10mins) periods of exercise produced the largest effect sizes. Since then studies 
have reported EIH in adults (Naugle et al., 2014; Naugle et al., 2016) and 
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adolescents (Stolzman and Bement, 2016) further supporting the hypoalgesic 
benefits of aerobic exercise. 
 
Despite this evidence, the mechanisms underpinning EIH are poorly understood 
although much of the literature focuses on both opioid and non-opioid mechanisms. 
Exercise-induced release of opioids at the peripheral, spinal and/or central sites has 
been previously associated with pain modulation and thereby EIH (Thoren et al., 
1990). Indeed, opioid antagonists, naloxone and naltrexone, have been previously 
demonstrated to attenuate the analgesic response after exercise (Mogil and 
Belknap, 1996). However, neurotransmitters such as, norepinephrine and serotonin 
(Bobinski et al., 2015) have been identified as potential modulators of EIH providing 
evidence for non-opioid mechanisms. Similarly, there is evidence suggesting the 
involvement of N-methyl-D-aspartic acid subtype of excitatory amino acid receptors 
(NDMA; Price et al., 2000).  
 
There is also evidence which demonstrates that athletes have a higher pain 
tolerance than non-athletes. Tesarz et al. (2012) conducted a meta-analysis of 
cross-sectional studies comparing athletes to non-athletes. After a sensitivity 
analysis it was concluded that pain tolerance was indeed higher in athletes with a 
large effect size (Hedges’g=0.93, CI 0.52–1.34; I2=73%) although differences did 
exist between sport categories. For example, pain tolerance in endurance athletes 
was characterized by a moderate effect size but low heterogeneity (Hedges’g=0.65; 
CI 0.42-0.88; I2=6%) whilst in game sport athletes effect size and heterogeneity 
were high (Hedges’g=0.98, CI 0.40-1.57; I2 =86%). This suggests that whilst pain 
tolerance maybe higher in game sport, versus endurance athletes, the population is 
not homogenous which is typical of game sports as they often involve clusters of 
athletes with a variety of psychological and physical profiles. 
 
In contrast, the effect on pain threshold was less profound than pain tolerance 
(Tesarz et al., 2012). Whilst five studies reported higher pain thresholds, others 
either showed no difference, an effect size in the opposite direction (Ord and 
Gijsbers, 2003; Hedges’g=-0.57) or a “questionably high” effect size (d=2.22; 
Granges and Littlejohn, 1993; Tesarz et al., 2012). Moreover, a sensitivity analysis 
did not support the assumption that athletes have a higher pain threshold compared 
to normally active controls. This is because whilst pain tolerance is influenced by a 
variety of psychological and psychosocial factors such as self-efficacy and pain 
acceptance (Baker and Kirsch, 1991; Motl et al., 2007), pain threshold is stable and 
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unchanging (Tesarz et al., 2012). Furthermore, since pain threshold is not 
predicated by athletic status this means that the aforementioned findings, on pain 
tolerance being higher in athletes, are unlikely to be due to EIH. However, due to 
the nature of cross sectional studies it is uncertain to ascertain whether this 
observed difference is largely due to higher physical activity/exercise training levels 
or if athletes inherently possess higher pain tolerances thereby predisposing them 
to higher levels of physical activity. Consequently, interventional studies, with 
structured exercise training programs, would provide further insight to determine if 
exercise training can influence pain tolerance and at what intensity and/or duration. 
 
2.3 Effect of Exercise Training on Pain Tolerance 
 
To the author’s knowledge there are only three interventional studies that have 
examined the effect of exercise training on pain perception in humans (Anshel and 
Russell, 1994; Jones et al., 2014; O’Leary et al., 2017a). Despite these studies 
having variable outcomes what they all have in common is they measure and 
distinguish between pain threshold and tolerance (see section 1.1 for definitions). 
 
Anshel and Russell (1994), examined the effect 12 wks of exercise training had on 
pain tolerance and appraisal measured by profile of mood states. Participants 
(n=48) were unfit but otherwise healthy adults and randomly allocated into three 
exercise conditions; aerobic, resistance or combined aerobic and resistance 
exercise training in addition to a control (no exercise) group (n=12x4). Only those in 
the aerobic and combined exercise training increased their pressure pain tolerance 
to the upper (p<0.05). In contrast, resistance training alone, and no training, did not 
increase pressure pain tolerance.  
 
However, during their study the effect exercise training had on pain threshold was 
not recorded and pain tolerance was measured as the peak force rather than the 
duration that the stimulus could be endured (Anshel and Russell, 1994). Secondly, 
the volume and intensity of exercise performed were not accurately quantified. 
Consequently, it is impossible to determine the importance of exercise intensity 
and/or duration interpreting the results. Finally, no measures of maximal aerobic 
power were conducted and thus the influence of aerobic capacity on pain sensitivity 
could not be determined. Nevertheless, Jones et al. (2016) did investigate the 
impact of maximal aerobic capacity on pain sensitivity and observed no relationship 
between VO2 peak and pressure pain threshold or ischemic pain tolerance. 
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Therefore, Anshel and Russell (1994) provides some evidence that aerobic exercise 
training can increase pain tolerance within a healthy non-athletic population  
 
Jones et al. (2014) investigated the effect of aerobic training on pain sensitivity. In 
their study 24 healthy participants were assigned to either a control (n=12) or 
exercise group (n=12). Those in the training group performed 17-18 aerobic training 
sessions spread evenly over six weeks. Each session consisted of 30 min of cycle 
ergometry exercise performed at 75% HR reserve after a 5 min warm up at 35 W. 
Pressure pain threshold (PPT) was measured on four muscular sites on the right 
side of the body (trapezius, biceps brachii, rectus femoris and tibialis anterior) and 
ischemic pain tolerance via a modified submaximal ischemic tourniquet test (IPTT). 
Pain tolerance was defined as the total time participants could tolerate the handgrip 
exercise under ischemic conditions.  
 
After six weeks of aerobic training Jones et al. (2014) reported that, ischemic pain 
tolerance increased in >80% of participants by ~20% (p=0.036) but remained the 
same for participants in the control group (-3.75%; P=0.44). The duration of 
ischemic pain tolerance was not associated with any changes in VO2 peak in either 
the exercise (r<0.0001; p=0.99) or control group (r=0.18; p=0.17) as expected 
(Jones et al., 2016). However, when both groups were combined a weak 
association between the variables was found (r=0.21; p=0.02). This was explained 
due to how the groups were clustered in that there was little change in VO2 peak 
and pain tolerance in the control group but more significant changes in these 
variables in the exercise group. Pain threshold remained unchanged, after six 
weeks, in both groups in either the upper or lower body thus providing preliminary 
evidence that aerobic training increases pain tolerance but not pain threshold. 
 
However, as acknowledged by the authors (Jones et al., 2014), group allocation 
was not randomized and those in the exercise group received more attention as 
they were supervised for an additional 18 exercise sessions. This means that 
behavioural artefacts can not be ignored and must be considered as a potential 
cofounding factors to the observed increase in pain tolerance. Secondly, training 
occurred at 75%HR reserve. Although this is better than not prescribing an intensity 
at all (Anshel and Russell, 1994) this method has been criticized to cause variances 
in both perceptual and metabolic stress between individuals (Mann et al., 2013). 
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O’Connor and Cook (1999) proposed that by regularly approaching the limits of 
performance in training, such as during HIIT, pain tolerance can be vastly improved. 
Indeed, HIIT causes significant metabolic disturbances as indicated by the 
increased cardiovascular and perceptual response compared to a typical continuous 
training model (CONT; O’Leary et al., 2017b). Moreover, HIIT has been reported to 
be more effective at increasing exercise capacity than CONT (Daussin et al., 2008; 
Seiler et al., 2013), despite causing similar improvements in markers for aerobic 
fitness (i.e. VO2max and/or lactate threshold [LT]) (Daussin et al., 2008; Edge et al., 
2006; Poole and Gaesser 1985). Additionally, just six to seven sessions (~2wks) of 
HIIT has been demonstrated to increase markers for mitochondrial biogenesis. This 
includes but is not limited to an increase the in maximal muscle activity of; PGC1-a 
(↑30-40%), citrate synthase (↑20-39%), COX IV (↑24%) and acetyl CoA (↑32%) 
(Perry et al., 2010; Talanian et al., 2006; MacInnis et al., 2017; MacInnis and 
Gibala, 2017). Furthermore, studies employing HIIT protocols over similar periods of 
time have also observed an enhancement to maximal aerobic capacity (↑13% VO2 
peak; Talanian et al., 2006), peak work rate (↑8.67%; MacInnis et al., 2017) and 
time trial performance (↑1.1-2.7%; Garcia-Pinillos et al., 2017) similar to or greater 
than CONT. 
 
Consequently, O’Leary et al. (2017a) designed a study whereby participants were 
randomly assigned (1:1) into either a 6wks of HIIT or CONT group (n=10x2). The 
HIIT protocol was adapted from Weston et al. (1997) consisting of 6-8x5 mins 
exercise (interspersed by 1 min rest) intervals on a cycle ergometer at an intensity 
halfway between LT and VO2 max.  In contrast, the CONT protocol involved 
continuous cycling at 90%LT. These protocols were designed as such to address 
the previous limitation (Jones et al, 2014) of prescribing training based on HR 
reserve. After 6 wks TTE improved similarly in both groups but ischemic pain 
tolerance only increased following HIIT (39±29%; p<0.001) and not after CONT 
(4±16%; p=0.72). Since the pain tolerance test was performed in the arm, which 
was not involved in the training, and consisted of occluding blood flow it is unlikely 
that any changes to the nociceptor stimuli are responsible for this observation. 
Additionally, a reduction in pain sensitivity is an unlikely mechanism as no changes 
to pain ratings were observed during studies conducted both by Jones et al. (2014) 
and O’Leary et al. (2017a). Instead, within training data (O’Leary et al., 2017b) 
suggests that regularly approaching the limit of exercise tolerance during training 
was responsible for the increased pain tolerance. Indeed, participants in the HIIT 
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group always reached an RPE = 19 or 20 during the last 5 min of each sessions 
whereas participants in the CONT group never exceeded an RPE = 15. 
 
However, there are some limitations that exist with their study (O’Leary et al., 
2017a). The most prevalent was that performance was assessed by a time to 
exhaustion task halfway between LT and VO2 max. Whilst not necessarily a 
limitation in of itself (useful to determine exercise tolerance) it has limited 
external/logical validity to endurance performance (Currell and Jeukendrup, 2008). 
In the field of exercise physiology most interventions and mechanisms are explained 
using TTE tasks and/or exercises at a fixed exercise intensity. However, it is very 
rare for an athlete to exercise to volitional fatigue at a single exercise intensity 
(Currell and Jeukendrup, 2008). In other words, in the endurance sports 
performance is often entirely self-paced (Mauger et al., 2013; Mauger et al., 2014). 
Nevertheless, when comparing TTE to time trials of the same duration, Passfield 
and Coakley (2014) found no difference in average power output at 100 or 105% 
VO2max. Therefore, whilst it has been demonstrated that TTE tasks can be 
reflective of endurance performance caution should still be taken when interpreting 
these results when as the mechanisms which govern task failure and work rate 
regulation are very different constructs (Mauger et al., 2013). 
 
Indeed, whilst previous studies have attributed increased self-paced exercise 
performance to increased aerobic physiological markers it may also link to an 
improvement in the regulation of EIP. In self-paced endurance tasks, EIP allows the 
athlete to evaluate the relative “strain” of exercise on the body which can then be 
interpreted to make a conscious decision to increase or decrease exercise intensity 
(Mauger et al., 2013; Mauger et al., 2010). This has been demonstrated by Mauger 
et al. (2010) who gave participants (n=13) a 1.5 g of placebo (dextrose) or 
acetaminophen (ACT or paracetamol) 45 min before a 16.1 km time trial. 
Paracetamol is as an analgesic and its primary function is to inhibit the action of 
cyclooxygenase which itself is responsible for the production of prostaglandins that 
sensitive nociceptors (Mauger et al., 2010). Consequently, it relieves pain by 
elevating the pain threshold. Since its pharmacokinetics are unaffected by exercise 
and it has minor peripheral effects, any changes to exercise performance that are 
induced by ACT are likely to be attributable to changes in pain perception (Mauger 
et al., 2010). Indeed, results demonstrated that in the ACT condition 16.1 km TT 
performance increased by 2% and remained unchanged in the placebo condition. 
This was associated with an increase in mean power output and no change in EIP. 
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Therefore, EIP was demonstrated to be important in the regulation of exercise as 
ACT enabled participants to exercise at a greater intensity for the same level of 
perceived pain. This is supported by similarly designed studies (Foster et al., 2014; 
Delextrat et al., 2015) which also reported that ingestion of ACT in repeated sprint 
cycling performances can increase mean and/or peak power output with no 
changes to EIP.  
 
Astokorki and Mauger (2016) also highlighted the importance of EIP. In their study 
EIP was correlated with endurance performance and could accurately predict a 16.1 
km cycling time trial (r= - 0.83, p<0.01) and accounted for 7.5% of the variance after 
other factors for endurance performance were considered (p=0.002). Moreover, 
Whitehead et al. (2017) reported that, during an outdoor 16.1 km cycling TT, 
sensations of fatigue and pain were reported more frequently in earlier stages but 
reduced towards the final quartile of the race. The author attributes this to a variety 
of factors which include; perceived importance of the event, greater stress response 
during the initial portion of the race and participants employing specific coping 
strategies as the event progresses. Additionally, similar observations were made 
about verbalisations relating to the monitoring/alteration of pace indicating that the 
riders use sensations of pain and/or discomfort as a tool to appropriately plan their 
pacing strategy (Whitehead et al., 2017). Thus, these studies demonstrate that not 
only can tolerance of EIP be a predictor of endurance exercise performance but 
also that during “real world” scenarios athletes use sensations of pain during 
exercise to alter their pacing strategy. 
 
It is also uncertain how much HIIT is needed to elicit improvements to pain 
tolerance. Participants in O’Leary et al. (2017a) exercised for a combined total of 18 
HIIT or CONT sessions equating to approximately six weeks in duration. To the 
author’s knowledge, no study to date has investigated whether pain tolerance or 
self-paced exercise performance can increase following a short period of HIIT. 
Consequently, not only is it unclear whether a short period of HIIT could increase 
pain tolerance but also if subsequent training sessions further this effect. 
 
Finally, it is also unclear why pain tolerance increases following HIIT. Whilst 
previous studies have attributed this to alterations in the signalling response to 
afferent signals from nociceptors (Jones et al., 2014), this is unlikely as pain 
threshold remains unchanged after period of aerobic exercise training (Jones et al., 
2014; O’Leary et al., 2017a; Stevens et al., 2017). Instead, it is more likely 
22 
 
psychological factors such as; pain catastrophizing (Sullivan et al., 2000), anxiety 
(Geva and Defrin, 2013; Roebuck et al., 2018) and self-efficacy (Motl et al., 2007; 
Johnson et al., 2011), are important at regulating this response as indicated by 
cross sectional (Tesarz et al., 2012) and training (Anshel and Russell, 1994) 
evidence. Specifically, Anshel and Russell (1994) observed that after 12wks of 
aerobic exercise training pain appraisal, as measured by profile of mood states, 
improved (increase in vigour as well as decrease in tension and depression). 
However, the POMS has been criticized in the past (Leunes and Burger, 2000) and 
does not necessarily provide a complete psychological profile as intended.  
 
Therefore, the purpose of the current study was to determine if three or six HIIT 
sessions had any effect on ischemic pain threshold, tolerance and ratings. The 
impact of HIIT on self-paced exercise performance as well as pain catastrophizing 
and anxiety was also investigated. The reason for not employing more HIIT 
sessions or a control group was due to the scope of the project. Additionally, past 
studies have observed increases in self-paced exercise performance, exercise 
capacity and physiological aerobic capacity markers following HIIT (Perry et al., 
2010; Talanian et al., 2006; MacInnis et al., 2017; Garcia-Pinillos et al., 2017) 
further justifying this decision. 
 
2.4 Hypotheses 
 
Firstly, it was hypothesized that three and six sessions of HIIT would increase 
ischemic pain tolerance, 5 km TT performance and decreased pain catastrophizing 
and anxiety. Secondly, it was hypothesized that six HIIT sessions would produce a 
markedly greater response in the aforementioned variables than three HIIT 
sessions. Finally, it was hypothesized that a training effect would occur only 
following six HIIT sessions reflected by an increase in power output for the same 
heart rate response.  
 
3 Methods 
 
3.1 Participants 
 
In total 18 healthy adults (11 males, 7 females) volunteered to participate in the two-
arm parallel group. The study was approved by the institutional ethics review board 
and conducted in accordance with the Declaration of Helsinki. All participants were 
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recruited in Oxford, UK through advertisements placed on billboards/study tables 
throughout the campus, posts to social media, word of mouth and emails to coaches 
of local sports clubs (hockey, triathlon, cycling and cricket). The eligibility criteria 
were: 1) Healthy with no history of chronic disease or chronic pain; 2) not taking any 
pain or pain-related medication; 3) between the ages of 18–55yrs; and 4) not 
currently diagnosed with depression (Thompson et al., 2016). All participants were 
required to complete a PAR-Q form and provide informed consent before taking part 
in the study. After completing baseline assessments participants were randomly 
assigned into one of two exercise groups: three (n=9, Ex-1), or six HIIT sessions 
(n=9, Ex-2).  
 
3.2 Experimental Procedure 
 
All participants completed experimental trials before and after three or six HIIT 
sessions depending on their group allocation (see figure 1). All testing and training 
sessions were separated by at least 24 hrs and lasted no longer than an hour. For 
the initial baseline assessment instructions were given to each participant telling 
them to arrive 2 hrs postprandial having already abstained from exhaustive exercise 
(48 hrs), alcohol (24 hrs) and caffeine (12 hrs). Participant’s anthropometric 
measures and response to the PCS and PASS-20 questionnaires were firstly 
assessed. This then was followed by measuring their maximal voluntary grip 
contraction (MVC) and ischemic pain tolerance (see section 3.3). A VO2max test 
was conducted to determine maximal aerobic capacity to establish general aerobic 
fitness and determine the linear factor for training (see section 4.5.1). The second 
visit involved a 5 km time trial the details of which are provided in section 4.5.2. On 
subsequent assessment days the following measures were obtained in order; 
resting HR, PCS and PASS-20 questionnaire responses, MVC, IPTT and 5 km time 
trial. 
 
3.3 Ischemic Pain Tolerance Test (IPTT) 
 
Before commencement of the IPTT participants were required to establish their 
MVC so that the required force needed to be produced by isometric contractions 
could be set (30% MVC) . This consisted of three maximal grip contractions using a 
handgrip dynamometer (Takei, T.K.K 5401, Japan). Each contraction was 
separated by 1min and participants were instructed to bend the elbow whilst 
keeping their arms at their side but not touching the body. Standardized verbal 
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encouragement was given throughout this test and the best of the three measures 
was determined as their MVC. 
 
After the participant’s MVC was determined they then completed an IPTT. The IPTT 
is a modification of the ischemic exercise test and the IPTT protocol used for this 
study is the same as previously described (Jones et al., 2014; O’Leary et al., 
2017a).  
 
Throughout the duration of the IPTT participants were seated and a cuff was placed 
around their upper dominant arm. Subjects were first instructed to raise this arm 
above their head for 60 s to cause exsanguination. After 60s the sphygmometer 
was rapidly inflated to 200 mmHg to ensure complete arterial occlusion before the 
participant lowered their arm to commence the test. The IPTT consisted of a series 
of 4 s isometric contractions, at 30%MVC, using the previously described force grip 
dynamometer and software (4.3.1), with visual feedback of the grip force displayed 
on a nearby computer screen (Toshiba, Satellite Pro, L670-170). Each contraction 
was separated by 4 s of rest. The test lasted until the participant could no longer 
continue. A separate PC monitor (Dell, Ultrabook, Latitude E7470) was also 
positioned adjacent to the grip force visual feedback monitor and displayed a 
presentation of slides which switched between green (contraction) and red 
(relaxation) accompanied with an auditory tone.  
 
Prior to assessment participants were asked to note when sensations of discomfort 
became painful. This was determined as their ischemic pain threshold whereas the 
total time participants could sustain handgrip contractions was defined as ischemic 
pain tolerance. Subjective ratings of pain (PPI) were also obtained every 30s from 
pain threshold. Pain ratings were recorded using a 11-point numeric pain rating 
scale (NRS-11; figure 7) with three anchor points; 0=“No pain, 5=“Moderate Pain” 
and 10=“Worst possible pain” and participants were told they could rate their pain in 
increments of 0.1. Systematic reviews (Williamson and Hoggart, 2005; Hjermstad et 
al., 2011) have demonstrated that the NRS-11 has significant correlations and 
agreement levels with the 100mm VAS (r=0.84-0.94). Moreover, the NRS-11 is 
argued to be superior primarily due to its high compliance and ease of use 
(Hjermastad et al., 2011). Furthermore, to blind participants of elapsed time, PPI 
was obtained at random intervals although these data were not recorded. Finally, 
during the test HR was also obtained every 30 s using online telemetry (T31, Polar, 
Finland; FT1, Polar, Finland).  
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Participants had complete control over the start and cessation of the test. They 
pressed a button to inflate and deflate the cuff, starting and terminating the test 
respectively. A 10 min time limit was set but not known to the participants who were 
only told to sustain handgrip contractions for as long as possible (no participant 
reached this time limit). The investigator also terminated the test if the participant 
themselves requested or they failed to reach 30%MVC. 
 
3.4 Exercise Tests 
 
All exercise tests were conducted on an electromagnetically braked cycle ergometer 
(Corival, Lode, Netherlands) at a self-selected cadence above 60 rpm. HR was 
measured using online telemetry (Polar HR sensor, H1) and RPE was determined 
using the 6-20 Borg scale (figure 9) with 6=“No exertion at all” and 20=“Maximal 
exertion”. All tests were conducted by the same investigator.  
 
3.4.1 Maximal Aerobic Capacity and Linear Factor Assessment 
 
To assess for maximal aerobic capacity a VO2max test, to volitional exhaustion, was 
conducted at baseline using a step protocol, previously used in our laboratory 
(Jones et al., 2017). The step protocol was chosen over a ramp protocol due to the 
former providing more valid measurements for gaseous exchange threshold data 
used for subsequent linear factor assessment (Zuniga et al., 2014). 
 
Specifically, the protocol first consisted of participants resting for 2 min, followed by 
a warm up at 50 W for 5 mins at a self-selected cadence. Thereafter, the resistance 
progressively increased until volitional exhaustion occurred using a step protocol 
(25 W every 3 mins). The test was terminated by the investigator if either a cadence 
of 60 rpm could not be maintained for 5 s or when the cadence fell below 60 rpm 
three times (O’Leary et al., 2017a). Inspired and expired gases were collected and 
recorded using online breath-by-breath analysis (Cortex Metalyzer 3B, Leipzig, 
Germany). Measures of HR and RPE were obtained every minute and at 
exhaustion. Data for VO2 was averaged over 10 s periods with the highest 30 s 
average value representing VO2max. Peak work rate was defined as the highest 
work rate achieved during the step test. 
 
Gas exchange threshold (GET) was determined by using three main criteria 
previously described by Baily et al., (2009). The criteria were to identify either: 1) 
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The first disproportionate increase VCO2 when visually inspecting the plots of VCO2 
vs VO2; 2) Increase in expired ventilation (VE)/VC02 with no increase in inhalation 
(VE)/VO2; or 3) Increase in end-tidal O2 tension without a decrease in end-tidal CO2 
tension (V-slope method; Beaver et al., 1986). From this the VO2, VCO2 and work 
rate (W) at GET was then determined by using the closest data point as a 
reference. The same investigator was responsible for interpreting all the data 
obtained.  
 
Prior to all VO2max tests the gas analyser and volume transducer were calibrated in 
accordance with laboratory standard operating procedures and manufacturer 
guidelines. The gas analysers were calibrated using a gas standard (Cranlea, 110 L 
Calibration Gas, 5%CO2 and 15%O2) and the volume transducer with a 3L 
calibration syringe (Hans Rudolph, Series 5530). 
 
From the VO2max test each participant’s linear factor was determined so 
subsequent tests (3.4.2) and training sessions (3.6.1) could be conducted in linear 
mode. This ensures specificity in how the work rate responds to changes in pedal 
rate instead of the load being constant independent of the pedalling rate of the 
subject (hyperbolic mode). Consequently, participants can pace themselves to an 
RPE = 15 by adjusting their pedalling rate and the brain of the participant, not the 
experimenter, becomes “central command” or pacemaker of the exercise the 
importance of which is discussed further in section 3.6.1 (Noakes, 2011). The linear 
factor allows for adjustment in work rates as described by Driller (2012):    
 
 
 
Figure 2 – Equation which describes how work rate adjusts for changes in cadence (Driller, 2012). W = Work rate, L 
= Linear factor (constant value), RPM = Cadence. 
 
The linear factor was calculated from the VO2max test by obtaining the: average 
cadence, peak work rate, VO2max and work rate at GET as previously described. 
Furthermore, a desired delta was determined to calculate the linear factor. The 
desired delta is a percentage value that represents the equivalent work rate value 
between the VO2GET and VO2max. For example, if a desired delta of 50% is 
chosen then the VO2 value 50% between the VO2GET and VO2max will be selected 
and the corresponding work rate is used to determine the linear factor (Bergstrom et 
al., 2012). For the present study a desired delta of 70% was agreed upon by the 
investigators to ensure participants exercise above a steady state. Thus, the linear 
W = L • (RPM)2 
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factor was calculated using the equation described in figure 2 (Osterberg et al, 
2007; Jeukendrup et al, 1996). 
 
 
 
Figure 3 – Equation which describes how linear factor was calculated for the present study. L = Linear factor. GET 
= Work rate at gas exchange threshold. 70%∆ = 70% Delta. AC = Average Cadence 
  
3.4.2 5 km Time Trial 
 
After a period of 48-72hrs participants completed a 5 km time trial (TT) designed to 
assess self-paced exercise performance. The resistance during each participant's 5 
km TT protocol was based on their linear factor and ran on the software Lode 
Ergometry Manager, V.9. Not only have previous studies reported improvements in 
5km TT performance following similar periods of time (Hazell et al., 2010) but the 5 
km TT was also chosen for its high relative and (ICC > 0.95) absolute reliability 
(coefficient of variation < 3%) with various endurance performance variables 
(Dantas et al., 2015). 
 
Before test commencement participants were instructed to warm-up for 5min at a 
self-selected cadence against a low manual resistance (20-30 W). During the warm-
up instructions for RPE and perceived pain (EIP) scales were provided using similar 
instructions (see appendix section 8.8) adapted from Borg (1998) and Cook et al. 
(1997). Both scales were attached to a 178 cm stand approximately 50 cm directly 
in front of the handlebars. Participants then briefly stopped cycling until the flywheel 
went to a complete stop.  
 
Once the flywheel stopped the investigator counted down from five and the test 
started on “go” upon which participants were instructed to complete the 5 km TT as 
fast as possible. All participants were blinded to the elapsed time but knew their 
distance completed and remaining. Providing distance feedback this way has been 
previously shown to be preferred by as well as maximising TT pacing and 
performance in novice cyclists (Boya and Micklewright, 2016; Boya et al., 2017). 
 
Every 0.5 km measures of PO, RPE, HR and EIP (0-10) were obtained alongside 
how quickly, in seconds, the participant completed the 0.5 km. In all instances 
measures were obtained during the last 50 m of each 0.5 km with RPE obtained first 
followed by EIP then HR. Standardised verbal encouragement, unrelated to time, 
was given during the 5 km TT. To ensure all data were collected accurately values 
L = (GET+70%∆) / (AC)2 
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for time completion and PO were obtained after the test from the exported excel 
data sheet provided by the software. 
 
3.5 Questionnaires 
 
All participants completed the questionnaires described in the following section. In 
all instances the questionnaires were completed in silence and away from the 
influence of the investigators. They were always completed before commencement 
of any exercise test. 
 
3.5.1 Pain Catastrophizing Scale (PCS) 
 
The PCS (figure 6; Sullivan et al., 1995) consists of 13 items, each with different 
statements asking the participants to rate their thoughts and feelings when they are 
in pain. An example of one of the items is: “When I’m in pain…I feel I can’t go on.” 
Participants rated each statement on a 0-4 scale where: 0=“not at all”; 1=“to a slight 
degree”; 2=“to a moderate degree”; 3=“to a great degree”; and 4=“all the time”- to 
produce a maximum possible score of “52”. The internal consistency and validity of 
the PCS has been demonstrated by Osman et al. (1997) in healthy individuals and 
also reported a high test-retest correlation (r=0.75) across a period of 6 weeks for 
the same individual.  
 
3.6.2 Pain Anxiety Symptom Scale short form 20 (PASS-20) 
 
The PASS-20 (figure 7; McCracken et al., 1996) consists of 20 items, each of which 
is a statement relating to the participants anxiety towards pain. For example, “I can’t 
think straight when in pain”. Participants rated each statement on a 0-5 frequency 
scale with two anchor points where 0=“Never” and 5=“Always,” to produce a 
maximum possible score of 100. As the name preludes the PASS-20 is a short 
version of the original PASS which consisted of 40 items (McCracken et al., 1992). 
The internal consistency, reliability and construct validity of the PASS-20 has been 
previously demonstrated in both chronic pain patients (McCracken and Dhingra, 
2002) and healthy individuals (Abrams et al, 2007). 
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3.6 Training 
 
3.6.1 Exercise Sessions 
  
All exercise training sessions were completed on a cycle ergometer in linear mode 
(Excalibur, Corival Lode, Netherlands) and the HIIT protocol was adapted from 
O’Leary et al. (2017a). This consisted of 6 x 5 min exercise bouts interspersed by 1 
min recovery periods. However, to provide more external validity, participants were 
instructed to complete these exercise bouts at an RPE = 15 (i.e. “hard”) instead of 
exercising at a fixed exercise intensity halfway between lactate threshold and 
VO2max (O’Leary et al., 2017a). This is based on the anticipatory central governor 
model (Noakes, 2011) in which participants pace themselves based on various 
psychological (e.g. motivation, previous experience and self-efficacy) and 
physiological factors (fuel reserves, hydration status and heat accumulation) that 
occur before and during exercise.  
 
Measures of HR and PO were obtained every 60 s during each exercise bout. 
Before commencing each HIIT session participants warmed up against a 20-30W 
load for 5mins. Depending on group allocation participants either completed 3 (Ex-
1) or 6 (Ex-2) HIIT sessions with at least 24 hrs separating consecutive sessions. 
 
3.7 Anthropometric and Heart Rate Data 
 
3.7.1 Height 
 
Participant’s height was recorded at baseline (Harpenden, Stadiometer, Crymych-
Wales). Participants were instructed to stand straight with their back against the wall 
with their eyes facing forward. 
 
3.7.2 Body Composition 
 
Bioelectrical impedance analysis (BIA) was conducted at baseline (BC-418 
Segmental Body Composition Analyzer, Tanita, Tokyo Japan) before any exercise 
tests to assess for body fat %. For each assessment the mass of clothes was 
estimated using a visual guide. 
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3.7.3 Resting Heart Rate 
 
To obtain resting HR participants were instructed to lay down on a clinical laboratory 
bed and relax taking deep breaths in and out. Screens were set-up to separate the 
participant from the investigator and resting HR was determined as the value 
obtained after 60s although participants were not told this. HR values were obtained 
using online telemetry (Polar HR sensor, H1). 
 
3.8 Statistical Analysis 
 
All statistical analysis was conducted in SPSS (v.25, SPSS Inc, USA). Data were 
tested for homogeneity using the Levene’s Test for equality of variances and are 
presented as mean ± SD in text, tables and/or figures. 
 
Firstly, to compare baseline values between groups independent t-tests were 
conducted. Additionally, 2 x 2 ANOVAs were conducted to determine if any 
significant time interactions occurred and thus if HIIT had any effect on pain 
tolerance and threshold, average 5 km TT performance and questionnaire 
responses. Following a significant time interaction one-way ANCOVAS were also 
implemented to assess the differences between each group’s post training values 
with the baseline values used as a covariate. Changes in PO and HR variables 
during training were assessed using a series of 1 x 3/6 (group [Ex-1 or Ex-2] x time 
[HIIT Sessions 1-3 or 1-6 respectively] ANOVAS. Whenever the assumption of 
sphericity was violated, GreenHouse-Geisser corrections were applied. Confidence 
intervals (95%) were calculated, wherever appropriate, using the t-statistic (t = 
2.11).  
 
The alpha level for significance was accepted as p<0.05 and all tests were two-
tailed. Wherever appropriate effect sizes were calculated using Cohen’s “d” for 
which the following criteria were used; “small, d = 0.2”, “moderate d = 0.5” and 
“large, d = 0.8” (Cohen, 1988). 
 
4.0 Results 
 
4.1 Anthropometrics, Resting Heart Rate and Aerobic Fitness 
 
Table 2 summarises the anthropometric and VO2max data. Independent t-tests 
revealed no significant differences between groups in any of the variables. Training 
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had no impact on resting HR for participants in Ex-1 (Resting HR; Baseline = 67 ± 
10 bpm, Post-HIIT = 65 ± 11 bpm; p > 0.05) or Ex-2 (Resting HR; Baseline = 64 ± 
11, Post-HIIT = 64 ± 9 bpm; p > 0.05). 
 
 Ex-1 Ex-2 Total 
Anthropometrics  
Age (Yrs) 27 ± 10 28 ± 12 28 ± 11 
BW (kg) 71.79 ± 8.14 71.13 ± 13.14 71.64 ± 10.61 
Height (m) 1.74 ± 0.09 1.73 ± 0.12 1.74 ± 0.10 
Hours Ex/wk 6 ± 4 7 ± 3 6.39 ± 3.26 
Body Fat (%) 17.86 ± 7.76 18.79 ± 7.70 18.32 ± 7.52 
VO2max test  
VO2max (ml/kg/min) 48.89 ± 9.32 43.22 ± 8.18 46.06 ± 8.99 
Time to Exhaustion (s) 1520.9 ± 549.4 1384.9 ± 494.9 1452.9 ± 512.0 
PPO (Watts) 258 ± 53 241 ± 70 250 ± 61 
Max HR (bpm) 187 ± 13 184 ± 14 185 ± 13 
Max RPE (6 – 20) 19.6 ± 0.7 19.7 ± 0.5 19.7 ± 0.6 
Table 2 - Anthropometric and VO2max test measures of both intervention groups at baseline. Data are presented 
as  mean ± SD. BW = Body Weight. PPO = Peak power output. RPE = Rating of perceived exertion.  
* = Significant difference between groups, p<0.05 
 
4.2 Ischemic Pain Tolerance Test 
 
Data for the IPTT are summarised in table 3 and figures 4 - 7. No significant 
differences were observed between groups at baseline (Baseline; Pain Threshold CI 
95% = 71.92 s to 124.64 s, Pain Tolerance CI 95% = 217.87 s to 293.57 s). Training 
had no impact on pain threshold, tolerance, pain perception intensity or maximal 
voluntary contraction. 
 
  Baseline Post-HIIT 
Ex–1     
PPI Threshold (0 – 10) 2.7 ± 1.2 3.2 ± 1.6  
PPI Tolerance (0 – 10) 8.9 ± 0.6 9.0 ± 0.7  
MVC (N) 425.29 ± 100.52 424.04 ± 89.37 
Ex–2     
PPI Threshold (0 – 10) 2.7 ± 1.2 2.4 ± 1.6 
PPI Tolerance (0 – 10) 8.7 ± 1.7 9.1 ± 1.2  
MVC (N) 397.72 ± 102.04 396.42 ± 88.56 
Table 3 – Contraction and pain perception responses for the IPTT. Data are presented as mean ± SD. PPI = Pain 
perception intensity, MVC = Maximal voluntary contraction.  * = Significant difference between groups at baseline.  
** = Significant difference from baseline (p<0.05) 
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Figure 4 - Pain thresholds obtained for participants in group Ex-1 at baseline and post training. * = Significant 
difference from baseline (P < 0.05) 
 
 
 
 
 
 
Figure 5 - Pain thresholds obtained for participants in group Ex-2 at baseline and post training. * = Significant 
difference from baseline (P < 0.05) 
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Figure 6 - Pain tolerance values obtained for participants in group Ex-1 at baseline and post training. * = Significant 
difference from baseline (P < 0.05) 
 
 
 
 
 
 
Figure 7 - Pain tolerance values obtained for participants in group Ex-2 at baseline and post training. * = Significant 
difference from baseline (P < 0.05) 
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4.3 5 km Time Trial 
 
Table 4 summarises results for 5 km TT performances across all tests. No 
significant differences were observed between groups at baseline. Overall time trial 
performance (time completion and power output) and psychological parameters 
(RPE and EIP) did not change after HIIT. The HR response did decrease between 
tests, for both groups, as indicated by a significant time interaction and small effect 
size (Average HR; Baseline = 167 ± 13 bpm, Post-HIIT = 164 ± 12 bpm; F [1, 16] = 
5.61, p = 0.031, d = 0.27). However, an ANCOVA indicated no differences between 
the groups post values. 
 
  Baseline Post-HIIT 
Ex – 1 
Time Completion (s) 697.8 ± 191.5 722.0 ± 255.6 
EIP (0 – 10) 4.7 ± 2.1 4.3 ± 1.9  
RPE (6 – 20) 15.3 ± 1.1 15.3 ± 1.0 
Heart Rate (bpm) 169 ± 15  164 ± 13 
Power Output (Watts) 236 ± 68 237 ± 74 
Ex – 2 
Time Completion (s) 831.1 ± 277.1 780.1 ± 255.3  
EIP (0 – 10) 5.90 ± 0.88 5.4 ± 1.4  
RPE (6 – 20) 15.2 ± 1.2 16.0 ± 1.2  
Heart Rate (bpm) 165 ± 11 164 ± 12 
Power Output (Watts) 210 ± 77 220 ± 82  
Table 4 - Average responses from the 5 km time trial. Data are presented as mean ± SD. RPE = Rating of 
perceived exertion. EIP = Exercise induced pain.  
* = Significant difference between groups at baseline.  
** = Significant difference across time within the group (p=0.019)  
*** = Significant group x time interaction. 
 
4.4 Questionnaires 
 
No significant differences were observed between the groups at baseline for PCS 
(Ex-1 PCS = 25 ± 8; Ex-2 PCS = 20 ± 11, p > 0.05) and PASS-20 (Ex-1 PASS-20 = 
14 ± 8; Ex-2 PASS-20 = 13 ± 6, p > 0.05). Overall HIIT decreased pain 
catastrophizing as indicated by a significant time interaction and moderate effect 
size (F [1, 16] = 13.98, p=0.002, d = 0.56). A one-way ANCOVA revealed no 
differences in post HIIT values between groups for the PCS (see figures 8 – 9). 
Training had no impact on pain anxiety as indicated by the PASS-20 responses 
(see figures 10 – 11). 
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Figure 8 - Pain catastrophizing scale (PCS) responses obtained for participants in group Ex-1 at baseline and post 
training. * = Significant difference from baseline (P < 0.05). ** = Significant difference between groups post HIIT 
values (P < 0.05). 
 
Figure 9 - Pain catastrophizing scale (PCS) responses obtained for participants in group Ex-2 at baseline and post 
training. * = Significant difference from baseline (P < 0.05). ** = Significant difference between groups post HIIT 
values (P < 0.05). 
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Figure 10 - Pain anxiety symptom scale short form 20 (PASS-20) responses obtained for participants in group Ex-1 
at baseline and post training. * = Significant difference from baseline (P < 0.05). ** = Significant difference between 
groups post HIIT values (P < 0.05). 
 
Figure 11 - Pain anxiety symptom scale short form 20 (PASS-20) responses obtained for participants in group Ex-2 
at baseline and post training. * = Significant difference from baseline (P < 0.05). ** = Significant difference between 
groups post HIIT values (P < 0.05). 
 
4.5 Training Data 
 
Mean responses for RPE, HR and PO across sessions 1, 3 and 6 are summarized 
in table 5 and figure 12. No time interaction responses were observed for any of the 
0
5
10
15
20
25
30
P
A
SS
-2
0
 R
es
p
o
n
se
 (
0
 -
1
0
0
)
0
5
10
15
20
25
30
P
A
SS
-2
0
 R
es
p
o
n
se
 (
0
 -
1
0
0
)
38 
 
parameters. No significant differences were observed between groups from HIIT 
sessions 1–3. 
 
 
 
Figure 12 - Mean power output (watts) values obtained for each HIIT session for groups Ex-1 (Group 1) and Ex-2 
(Group 2). 
* = Significant difference between groups at baseline.  
** = Significant difference across time within the exercise group.  
*** = Significant group x time interaction 
 
 
 HIIT Session  
  1 3 6 
Ex – 1   
Heart rate (%HR max) 85.29 ± 5.94 82.44 ± 5.99 N/A 
Heart rate (bpm) 161 ± 15 156 ± 15 N/A 
Power Output (Watts) 201 ± 52 199 ± 51 N/A 
Ex – 2  
Heart rate (%HR max) 86.96 ± 6.67 84.06 ± 6.32 84.99±7.08 
Heart rate (b=pm) 157 ± 12 152 ± 13 155 ± 10 
Power Output (Watts) 177 ± 60 177 ± 69 177 ± 66 
Table 5 – Data for HIIT Sessions 1, 3 and 6 for both exercise groups. Data are presented as mean ± SD. RPE = 
Rating of perceived exertion. 
* = Significant difference between groups at baseline.  
** = Significant difference across time within the exercise group.  
*** = Significant group x time interaction. 
 
5.0 Discussion 
 
Briefly, the present study sought to examine the impact of short HIIT programs on 
ischemic pain perception, self-paced exercise performance as well as pain 
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or 5km TT performance. However, HIIT did decrease pain catastrophizing and 
average HR obtained during a 5km TT test.  
 
5.1 Ischemic pain tolerance test 
 
Overall ischemic pain tolerance did not change after HIIT. These results are 
inconsistent with Jones et al. (2014) and O’Leary et al. (2017a) who reported a 
20.3% and 39% increase in ischemic pain tolerance after 6wks of aerobic exercise 
training and HIIT respectively. Furthermore, these results are also inconsistent with 
longitudinal studies of athletes which have demonstrated pain tolerance to increase 
over the course of competitive seasons for swimmers (Scott and Gijsbers, 1981) 
and contact athletes (Thornton et al., 2017).  
 
The reason for this lack of change is likely due to the differences in protocol 
compared to O’Leary et al. (2017a). In their study participants in the HIIT group 
always reached an RPE of 19 or 20 during the last 5 min of each exercise session 
whilst those in the continuous training group never reached an RPE above 15. 
Since pain tolerance only increased following HIIT, the authors concluded that 
regularly approaching the limits of exercise tolerance was partially responsible for 
their observations. On the other hand, participants in our study were instructed to 
cycle at an RPE of 15 during each of the 6 x 5 min exercise bouts. Whilst this allows 
for more ecological validity, outside of an experimental setting, it also meant that 
participants did not approach the limits of their exercise tolerance which may explain 
the lack of change to pain tolerance.  
 
Furthermore, it is possible that changes in pain tolerance are only detected after a 
certain period. Indeed, our study was much shorter (3 and 6 HIIT sessions) 
compared to other training studies conducted by Jones et al., (2014) and O’Leary et 
al., (2017a) which were 18 aerobic and HIIT training sessions respectively. 
Additionally, Thornton et al. (2017) reported an effect size, d = 0.28, between 
participating and non-participating contact athletes after an 8-month season. Thus, 
even after an extended period of time only a small effect was observed for training 
that took place outside of a laboratory. However, more research is needed to 
determine exactly how long is needed to detect changes to pain tolerance using 
more robust experimental designs.  
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Nevertheless, increased pain tolerance has been previously attributed to the 
management of signals from type III and IV afferent fibres. A series of studies 
conducted by Amann et al. (2012) demonstrated that when feedback from type III/IV 
afferent fibres was attenuated not only was blood circulation and pulmonary 
ventilation compromised (Amann et al., 2010) but central motor drive was less 
restricted resulting in a significantly greater power output during the first half of a 5 
km TT (Amann et al., 2008). This allowed the central nervous system to “tolerate” 
peripheral locomotor muscle fatigue beyond levels measured during a placebo trial 
(i.e. intact afferent feedback).  
 
Consequently, increased pain tolerance after a period of exercise training has been 
(Jones et al., 2014) attributed to diminished signalling, in response to nociceptive 
signals from type III and IV afferent fibres. In theory, this would allow the central 
nervous system to increase both central motor drive and ventilatory/circulatory 
responses allowing greater development of peripheral locomotor muscle fatigue for 
a given exercise intensity. However, if this is the case then a change in pain 
threshold, in addition to pain tolerance, would be expected after a period of exercise 
training (Stevens et al., 2017). In contrast, previous evidence has demonstrated that 
pain threshold stays the same after aerobic exercise training (Jones et al., 2014; 
O’Leary et al., 2017). This is consistent with cross sectional evidence whereby 
athletes are demonstrated to have higher pain tolerance but similar pain thresholds 
to non-athletes (Tesarz et al., 2012). Our findings are in line with these observations 
whereby pain threshold remained the same after HIIT (p > 0.05).  
 
On the other hand, Hakansson et al. (2018) did report an increase in pressure pain 
threshold (d = 0.54) in the rectus femoris and tibialis anterior following 18 sessions 
of continuous training (30 min at 65-75% peak HR). However, participants in their 
study were overweight (BMI = 28.2 ± 2.5kg/m2) compared to predominately normal 
weighted individuals in Jones et al., (2014) and O’Leary (2017a) (according to BMI; 
cited Hakansson et al., 2018). Since PPTs have been demonstrated to differ in 
overweight/obese individuals it is possible that the effect of training may also be 
differential as a function of body size (Hakansson et al., 2018). 
 
Instead, it has been proposed that the consistent and frequent exposure to 
unpleasant sensory experiences causes participants to develop psychological 
coping techniques to tolerate these sensations (Stevens et al., 2017). Indeed, 
Roebuck et al. (2018) reported that ultra-marathon runners not only had higher cold 
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pain tolerance, but also lower levels of pain-related anxiety symptoms as measured 
by the PASS-20 questionnaire. Specifically, mediation analysis revealed that a 
reduction in pain-related escape and avoidance behaviours (measured by PASS-
20) accounted for 40% of the variance in pain tolerance. This behavioural dimension 
is representative of the extent to which an individual avoids or terminates activities 
based on the associated pain. Given that ultramarathon runners expose themselves 
regularly to unpleasant sensory experiences, as demonstrated by pain experienced 
during training and competitions, these results are not surprising (Simpson et al., 
2014). 
 
Specifically, we demonstrated that HIIT decreased pain catastrophizing scores 
similarly for both groups which was represented by a moderate effect size (d = 
0.56). This finding is novel in that, to the authors knowledge, this is the first 
interventional training study to demonstrate a change in pain catastrophizing in 
healthy participants. Nevertheless, this evidence is congruent with a three-month 
physical activity study of fibromyalgia patients conducted by Campbell et al., (2012). 
In their study not only did they observe a change in pain catastrophizing, but this 
coincided with a decrease in clinical pain ratings accounting for 14% of the variance 
(r2 = 0.14; p = 0.005). However, since no changes in pain perception occurred in 
this study it is uncertain whether this change in catastrophizing could have an 
impact on pain perception within a healthy population. Despite this, it has been 
demonstrated previously by Sullivan (2000) that athletes have lower PCS scores 
than non-athletes. However, regression analysis revealed that this difference in 
catastrophizing did not mediate differences in pain perception between athletes and 
non-athletes. Geva and Defrin (2013) also assessed and compared pain tolerance 
of athletes and non-athletes. Whilst athletes were observed to have a higher 
thermal pain tolerance and conditioned pain modulation, pain catastrophizing 
between the two groups was similar (p = 0.53). 
 
Similarly, a longitudinal study conducted by Thornton et al., (2017) demonstrated 
that contact athletes who regularly attended training over the course of an 8-month 
season not only had a higher pain tolerance (p = 0.04; d = 0.28) but also a lower 
pain catastrophizing score than “non-participating” athletes at the end of the season 
(p < 0.0001; d = 0.71). However, mediation analysis was not conducted and thus it 
is uncertain to what extent changes in pain catastrophizing were responsible for 
changes in pain tolerance. Furthermore, like the present study, measures to 
quantify participant’s pain specific self-efficacy (SE) or coping/management 
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strategies were not employed. This is important as these measures have also been 
demonstrated to influence pain tolerance and tolerance of pain sensations 
experienced during exercise.  
 
Specifically, Ord and Gijsbers (2003) demonstrated that competitive rowers who 
adopted high quality pain management strategies had significantly higher mean pain 
tolerances than the other group members (p < 0.01) whereas no difference was 
observed in the control group. Additionally, qualitative analysis of interview 
transcripts with ultramarathon runners, by Simpson et al. (2014), revealed that 
ultramarathon runners, who have a higher pain tolerance than untrained individuals 
(Roebuck et al., 2018), regularly use mental skills to cope with challenges during 
their races. They specifically describe the importance of participants using “positive 
inner dialogue” through difficult moments of the race which is closely reminiscent of 
positive self-talk. However, since only one participant mentioned using positive self-
talk to cope with pain associated with the race it is uncertain if this strategy is indeed 
effective at managing pain sensations experienced during exercise. Another 
strategy highlighted by Simpson et al. (2014) was that ultramarathon runners 
regularly used associative strategies to manage pain. This means that as pain 
increased during the race participants would increasingly focus on aspects of their 
run (e.g. putting one foot in front of the other or getting into a rhythm) rather than 
aspects which are dissociative from the pain (e.g. thinking about unrelated things to 
distract you).  Finally, in a randomized control study, Whitemarsh and Alderman 
(1993) not only demonstrated that stress inoculation training increased participants 
pain tolerance (via wall sit task) but this coincided with an increase of relaxation and 
self-instructional strategies. 
 
Regarding pain-specific SE, Motl et al. (2007) investigated the effect of pain-
specific-SE on muscle pain during moderate-high intensity cycle ergometry. Sixteen 
participants completed a TTE task followed by a 30 min submaximal bout of cycling 
exercise (80% VO2peak). Muscle pain was rated during the test and a SE scale was 
designed to assess an individual’s beliefs in their capability to tolerate moderate-
strong leg muscle pain during cycling without stopping. This scale was modified, 
from a previously existing scale, so that the SE measured was indeed specific for 
the study of pain during exercise experienced during the study (Motl et al., 2006). 
Results demonstrated that SE was inversely correlated with peak muscle pain 
obtained during the TTE test (r= -0.45, p=0.04) and muscle pain experienced during 
the second half of the submaximal test (r= -0.45 to -0.69, p<0.05). Additionally, 
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Keefe et al. (1997) observed that patients with higher SE had a higher pain 
tolerance compared to those with a low SE towards clinical pain (d = 1.69; p = 0.03). 
Furthermore, a cross sectional study demonstrated that SE accounted for 40% of 
pain tolerance variance between athletes and non-athletes (Johnson et al., 2011). 
However, these findings should be interpreted with caution as SE was measured 
using a non-validated single item questionnaire.  
 
On balance, it is uncertain whether any changes of these psychological variables 
may have changed in response to HIIT or had an impact on the changes to pain 
tolerance observed by Thornton et al. (2017). Thus, it is important that future 
research considers measuring different psychological variables to examine if and 
how they are impacted by periods of structured training.  
 
Another limitation of this study was that the questionnaires, PCS and PASS-20, 
were not analysed for each of their respective subscales. This is important as 
previous studies have demonstrated that differences between athletes and non-
athletes can be specific and explained further by analysing certain subscales within 
a questionnaire.  For example, in a study conducted by Sullivan (2000) whilst 
athletes had a lower PCS score (p < 0.05) further analysis revealed this was only 
true for rumination and helplessness but not magnification. Additionally, a recent 
study demonstrated that only the escape and avoidance subscale (measured via 
the PASS-20) was responsible for mediating 40% of the pain tolerance variance 
between athletes and non-athletes whereas the other subscales (cognitive anxiety, 
physiologic anxiety and fearful thinking) did not account for this difference (Roebuck 
et al., 2018). 
 
Furthermore, we did not observe any changes to pain anxiety as indicated by the 
PASS-20 questionnaire scores. These findings are inconsistent with cross sectional 
evidence whereby athletes have been demonstrated to have lower pain anxiety 
scores than non-athletes via the PASS-20 (Roebuck et al., 2018) or fear of pain 
questionnaire (Geva and Defrin, 2013). Specifically, Geva and Defrin demonstrated 
that anxiety, measured via fear of pain questionnaire, was negatively correlated with 
the training hours per week (r = -0.36; p < 0.05). However, two major limitations 
must be considered when interpreting these findings. Firstly, training hours cannot 
be validated as they were self-reported by participants. Secondly, no further 
information for training was provided other than the number of hours per week and 
thus the impact of training intensity and/or duration cannot be determined.    
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The lack of change in pain anxiety is most likely due to our participants already 
having a low PASS-20 score at baseline when compared to other non-athletic 
samples (Abrams et al., 2007). Indeed, in a study of 155 healthy but non-athletic 
people the total score for PASS-20 was 24 ± 13 (95% CI 21.9 to 26.1; Abrams et al., 
2007). When compared to our participant’s PASS-20 baseline responses in groups 
Ex-1 and Ex-2 (Ex-1 PASS-20 = 14 ± 8; Ex-2 PASS-20 = 13 ± 6) this difference 
becomes apparent.  
 
It remains uncertain why participants, in our study, exhibited such low pain anxiety. 
Whilst, the PASS-20 questionnaire was initially developed for patients suffering from 
chronic pain it has been validated in nonclinical populations having concurrent 
validity with related measures such as anxiety sensitivity (anxiety sensitivity index; r 
= 0.56), fear of pain (Fear of Pain Questionnaire; r = 0.53) and pain catastrophizing 
(PCS; R = 0.38) (McCracken et al., 1992). Additionally, the PASS-20 questionnaire 
has been shown to have good internal consistency (α = 0.81) and convergent 
validity with the original scale consisting of 40 items (PASS-40; Abrams et al., 
2007). Consequently, it is unlikely that the questionnaire itself or its use within a 
non-clinical population would explain these observations. Furthermore, whilst our 
participants were healthy and active, they were untrained as indicated by their 
VO2max and resting HR values (see section 4.1). Therefore, it is also unlikely that 
training status would explain these observations as would expected of triathletes 
(Geva and Defrin, 2013) or ultramarathon runners (Roebuck et al., 2018).  
 
Consequently, future research should not only investigate the effect longer HIIT 
programs have on pain tolerance but also determine if and to what extent pain 
management/coping strategies (Ord and Gijsbers, 2003), SE (Motl et al., 2007; 
Ghazaie et al., 2015), self-efficacy, anxiety and pain catastrophizing explain these 
changes. Finally, subscales of questionnaires, such as the PCS and PASS-20, 
should be considered and analysed to identify which dimensions of pain perception 
are responsible for any observed changes in pain tolerance. 
 
5.2 Training and 5 km Time Trial Performance 
 
Overall, 5 km TT performance was not affected by HIIT when considering 
completion time and power output. Additionally, average RPE and EIP obtained 
during the 5km TT were not affected by HIIT. Mean HR decreased from baseline 
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with was characterized by a small effect size (d = 0.27). Furthermore, there were no 
changes in HR and PO responses across subsequent HIIT sessions.  
 
Firstly, the lack of a training effect to participants in Ex-2, represented by no change 
in PO, is surprising as O’Leary et al. (2017b) demonstrated PO increased when 
comparing participant’s first and last HIIT sessions (202 ± 47 W vs 228 ± 45; p < 
0.05; d = 0.57) using a similar protocol. However, the short duration (three or six 
HIIT sessions) of the HIIT programs in the present study, compared to O’Leary et al. 
(2017b), may explain why no change in PO was observed (18 sessions). 
Furthermore, the lack of a training stimulus may explain these observations. Indeed, 
when comparing the first HIIT sessions to O’Leary et al. (2017b) on average 
participant’s HR is 10-12bpm lower which is characterized by a small-moderate 
effect size (d = 0.21-0.71) when comparing both studies first and last HIIT sessions. 
This is likely due to differences in protocols in that the present was self-paced and 
the one chosen by O’Leary et al (2017b) was prescribed. 
 
More specifically in the study conducted by O’Leary et al. (2017b) participants in the 
HIIT group were prescribed a fixed intensity (202-228W) halfway between lactate 
threshold and VO2max, typical of most HIIT protocols (MacInnis and Gibala, 2017). 
Therefore, participant’s in their study consistently reached the limits of their exercise 
tolerance as indicated by RPE ratings (RPE = 19 or 20 during last 5 min stage). In 
contrast, our adapted protocol involved participants cycling in linear mode at a fixed 
RPE = 15 which allows adjustments in work rate based on the participants cadence 
(see figure 1). However, whilst this allows participants to set the pace, and thus has 
more ecological validity outside of an experimental setting, they ultimately exercised 
at a lower work rate (Noakes, 2011; 177-200W) leading to a markedly decreased 
HR response.  
 
One explanation for this observation comes from the central governor model 
(Noakes, 2011) which predicts that behaviour modification ensures that 
homeostasis is protected. Thus, it is possible that the participant’s brains 
unconsciously chose to exercise at an intensity that they deemed as sustainable for 
the expected duration of the exercise (Noakes, 2012). Indeed, it has been 
demonstrated that athletes choose different pacing strategies based upon the actual 
duration of the race (Tucker et al., 2006). For example, analysis of world record 
performances shows that, except for the 800m, athletes speed up at the end of 
longer races which is clearly an example of an end-spurt (Tucker et al., 2006). 
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However, since our participants exercised at a fixed RPE this reserved energy was 
not needed and thus participants did not exercise to the limits of their exercise 
tolerance. Therefore, it is likely that the physiological demand in the current study 
protocol did not cause sufficient metabolic disturbances to promote aerobic 
physiological adaptations. However, since HR data at ventilatory thresholds 
obtained during the VO2max tests, or any other physiological data, were not 
collected this is cannot be known for certain. On the other hand, the lack of 
metabolic disturbance and thus physiological adaptations would partially explain the 
lack of change in 5 km TT performance. 
 
One type of training which has been demonstrated to cause such metabolic 
disturbances and improve endurance performance is sprint interval training (SIT). 
Indeed, studies employing SIT protocols over similar periods of time to that of the 
present study (6-7 sessions) have observed increased sporting performance for 
both exhaustion (Burgomaster et al., 2005; Hazell et al., 2010) and self-paced 
exercise tasks (Burgomaster et al., 2006; Hazell et al., 2010; Jones et al., 2017). It 
has been proposed that due to the increased flux between exercise and rest, SIT 
protocols may result in greater perturbations to muscle milieu than HIIT (Jones et 
al., 2017). Furthermore, during SIT, PPO declines which is a primarily due to falling 
phosphocreatine (PCr) stores in the muscles (Bogdanis et al., 1996). Decreased 
PCr availability, combined with repeated attempts to generate PPO, stimulates both 
oxidative phosphorylation and glycolysis the former of which becomes more 
predominant during successive efforts (Hazell et al., 2010). Therefore, in shorter 
periods of time (i.e. 6 sessions), SIT is more likely to cause significant metabolic 
adaptations than HIIT and thus improve endurance performance.   
 
Additionally, the linear factor, and the tests chosen to calculate it, are also factors to 
consider when regarding the lack of training stimulus. The test chosen for the 
present study was a VO2max test which involved participants cycling for 5 min at 50 
W (warm up) with the resistance increasing by 25 W every 3mins thereafter until 
volitional exhaustion (Jones et al., 2017). Consequently, this protocol involved long 
stages with relatively small increases in resistance. Such protocols have been 
demonstrated to underestimate VO2max (Julio et al., 2017) and peak work rate 
values (Amann et al., 2004) as the energy requirements are significantly higher 
compared to shorter protocols for any given work rate resulting in greater levels of 
exhaustion. Considering both variables are crucial to calculating the linear factor 
(see figure 1) this may of lead to each linear factor being underestimated. On the 
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other hand, considering the difference in work rate values between the present and 
O’Leary (2017b) HIIT protocols, a more likely issue is the impact of the cadence to 
power output ratio in that small variations in cadence result in markedly variable 
power outputs. For instance, using the equation provided in figure 1, an increase of 
5rpm with a linear factor of 0.031 (from rpm = 80 to 85) results in the work rate 
increasing by over 20 W (~198 W to 224 W). This itself would be enough to account 
for the PO differences observed between that of the present and the study 
conducted by O’Leary et al., (2017b). However, data for cadence were not recorded 
during the present study and thus the impact of varying cadence on power output 
can not be quantified. 
 
Therefore, whilst this specific self-paced exercise training protocol may have more 
ecological validity, outside an experimental setting, its inefficient at improving 
endurance performance over short periods of time (3 and 6 HIIT sessions). 
Consequently, although future research should consider employing self-paced HIIT 
protocols, they should not compromise the training stimulus response and should be 
tested thoroughly before using them in a training study. For instance, future 
research could consider employing similar protocols to the present but at a higher 
fixed RPE and adjusting work rate through PO and not cadence. Indeed, Astokorki 
and Mauger (2016) instructed participants to cycle at a fixed RPE = 16 who could 
adjust their PO to maintain this perception of effort. However, since the test was 
terminated if the participant’s PO dropped below 70% of their initial PO, the duration 
of the test was not fixed (TTE = 28:35 ± 13:40 min:s). As a result, future research 
would need to take this into consideration when adapting this into a training 
protocol. 
 
Another factor to consider is the 5 km TT test itself. Hazell et al. (2010) reported a 3-
5% increase in 5 km TT performance after 2wks (6 sessions). However, this was 
following SIT and the 5 km TT protocol differed drastically. Firstly, participants in 
Hazell et al. (2010) were given instantaneous computer video image feedback 
during their 5 km TT racing against an image of themselves. Furthermore, they were 
provided additional measurements including; time elapsed, previous best time, 
current speed and distance behind/ahead of the competitor. Therefore, whilst the 5 
km TT has been reported to be sensitive to changes in performance (sensitivity 
index>1), it is unclear if a longer test (i.e. 40km TT; Stepto et al., 1999) would have 
been necessary to detect changes in self-paced exercise performance after such 
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short HIIT programs and to what extent motivation is a cofounding factor (Dantas et 
al., 2015).  
 
Finally, one observation, regarding the 5 km TT, was that mean HR decreased by 
~4bpm with no change to resting HR (see table 4; p = 0.031, d = 0.27) from 
baseline. Indeed, previous evidence demonstrates submaximal HR response to 
decrease following aerobic training by 12-15 bpm with little change to resting HR 
(McArdle et al., 2014). This is likely due to greater vagal dominance caused by; 
increased parasympathetic activity, decreased sympathetic discharge and reduced 
intrinsic firing rate of the sinoatrial node pacemaker (Lee et al., 2003; Schaefer et 
al., 1992). However, HR variability between tests may also explain this observation 
as non-significant correlations where reported by Dantas et al. (2015) when 
comparing relative HR responses from two 5 km TT tests (ICC = 0.21; p > 0.05). 
 
6.0 Conclusions and Future Research Directions 
 
On balance, results demonstrated measures for pain threshold, tolerance and 
anxiety did not change after three or six sessions of HIIT. However, individual’s pain 
catastrophizing did decrease similarly following three or six HIIT sessions as 
measured by PCS questionnaire responses. However, subscales of questionnaires, 
PCS (rumination, helplessness and magnification) and PASS-20 (escape 
avoidance, cognitive anxiety, physiologic anxiety and fearful thinking), were not 
separately analysed. Furthermore, other psychological variables which have been 
shown to impact pain tolerance were not measured such as pain-specific SE and 
pain coping/management strategies. Thus, future research should ensure to 
analyse subscales of questionnaires and consider the impact of structured training 
programs, such as HIIT, on other psychological variables in relation to changes in 
pain tolerance. 
 
Self-paced exercise performance did not change after HIIT, but mean HR did 
decrease between subsequent tests. The former can be largely attributed to the 
HIIT protocol employed in this study. Though the self-paced nature of our HIIT 
protocol has more ecological validity outside an experimental setting, such as a gym 
environment, the physiological and therefore training response was not as profound 
as previous “prescribed” protocols. Therefore, when designing self-paced exercise 
training protocols, future research should ensure that the training stimulus is not 
compromised. Furthermore, self-paced protocols should allow participants to adjust 
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their work rate by changes to power output and not cadence as small variations in 
the latter has the potential to cause significant changes to the training response. 
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7.0 Appendices
Figure 13 - Typical setup for the ischemic pain tolerance test. Privacy screens (Drive, Panel Privacy Screen, 2006) were set-up to ensure participants 
performed the test with minimal outside influence 
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7.1 Physical Fitness Background: 
 
Participant ID: ………………………………………………… 
 
Physical Fitness Background  
Age (yrs)  
Hours of exercise (per week)  
Category of exercise (e.g Cardio, weights etc…)   
How long have you been training within this sport (in 
months)  
 
 
 
Have you ever had respiratory problems in the past or currently? 
Yes/No 
If yes then explain: ………………………………………………………… 
 
Have you ever had an injury causing you to not perform in exercise before? 
Yes/No 
If yes then please explain: …………………………………………………. 
 
Have you been ill within the past 4 weeks? 
Yes/No 
If yes then explain: ………………………………………………… 
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7.2 Anthropometric and aerobic capacity measures: 
 
Anthropometric Measures  Metalyzer 
Body Weight (kg)   
Height (cm)  
Body fat (%)  
Aerobic Capacity  
VO2max (ml/kg/min)  
Time to exhaustion (secs)  
 
  Elapsed Time (mins) 
 75 Watts 100 Watts 125 Watts 150 Watts 175 Watts 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
HR (bpm)                
RPE (6-20)                
 200 Watts 225 Watts 250 Watts 275 Watts 300 Watts 
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
HR (bpm)                
RPE (6-20)                
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7.3 5 km Time Trial (delete as appropriate): Baseline / Week 1 / Week 2 
 
Participant ID: ………………………………………………… 
 
Laptop number: …………… Data entered: ………………. 
 
  
Elapsed Distance (kilometres) 
 0.5 km 1km 1.5 km 2km 2.5 km 3km 3.5 km 4km 4.5 km 5 km 
Time 
(mins:secs) 
          
Heart rate 
(bpm) 
          
RPE (6-20)           
PPI (0 - 10)           
Power 
output 
(Watts) 
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7.4 Ischemic pain tolerance test (delete as appropriate): Baseline / Week 1 / Week 2 
 
Participant ID: ………………………………………………… 
 
Ischemic pain test  
Resting HR (bpm)  
MVC (N)  
Pain threshold (secs)  
Pain tolerance (secs)  
 
 Time since pain threshold (secs) 
 0  30 60 90 120 150 180 210 240 270 300 330 360 390 420 
Pain (0-10)                
HR (bpm)                
 450 480 510 540 570 600  END        
Pain (0-10)                
HR (bpm)                
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7.5 Training session (delete as appropriate): Week 1 / Week 2   Session 1 / 2 / 3  
 
Participant ID: ………………………………………………… 
 
Laptop number: …………… Data entered: ………………. 
 
 Elapsed Time (seconds) 
 60 120 180 240 300 360 420 480 540 600 660 720 
HR (bpm)             
RPE (6-20)             
PO (Watts)             
 780 840 900 960  1020 1080 1140 1200 1260 1320 1380 1440 
HR (bpm)             
RPE (6-20)             
PO (Watts)             
 1500 1560 1620 1680 1740 1800 1860  1920 1980 2040 2100  
HR (bpm)             
RPE (6-20)             
PO (Watts)             
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7.6 Questionnaires and Scales 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 – Pain Catastrophizing Scale developed by Sullivan et al. (1995) 
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Figure 15 – Pain Anxiety Symptom Scale Short Form-20 developed by McCracken et al. (1996) 
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Figure 16 – 11-Point (0-10) Numeric Pain Rating Scale. Used to measure pain perception during the IPTT, CPT 
and 5 km TT  
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Figure 17 – Rating of Perceived Exertion (RPE) scale developed by Borg (1970) 
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7.7 Physical Activity Readiness Questionnaire 
 
 
UNIVERSITY
BROOKES
OXFORD
 
Exercise and Sports Science Research Group 
School of Biological and Molecular Sciences 
Oxford Brookes University  
Oxford  
OX3  0BP 
Physical Activity Readiness 
Questionnaire (PAR-Q) 
 
Please read the following questions carefully and answer as accurately as possible. 
 
Medical history Yes No 
1. Has a doctor ever said you have heart trouble?  ____ ____ 
2. Do you suffer frequently from chest pains?   ____ ____ 
3. Do you often feel faint or have spells of dizziness?  ____ ____ 
4. Has a doctor ever said you have epilepsy?   ____ ____ 
5. Has a doctor ever said you have high blood pressure?
  
____ ____ 
6. Has a doctor ever said you have diabetes?   ____ ____ 
7. Has a doctor ever said you have asthma?   ____ ____ 
8. Do you have a bone, joint or muscular problem which 
may be aggravated by exercise? 
 
____ 
 
____ 
9. Do you have any form of injury?   
  
____ ____ 
10. Are you currently taking any prescription medications?
  
____ ____ 
11. Have you suffered from a viral illness in the last two 
weeks 
____ ____ 
Adpated from Chisholm, D. M., Collins, M. I., Davenport, W., Gruber, N. and Kulak, L. L. (1975) PAR-
Q validation report British Columbia Medical Journal 17. 
 
If you have answered YES to any of the above questions please inform a member of 
the research team. 
 
If any of the information you have provided changes in any way, you must inform a 
member of the teaching staff BEFORE you participate in any physical assessment 
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If, prior to participation in a physical assessment, the answer to any of the following 
questions is ‘yes’, I will inform a member of the teaching staff 
 
 
 
 
 
 
 
 
 
 
 
 
I understand that the information provided above is important, and I will inform a 
member of staff if I believe there is a medical reason I should not participate in 
physical assessments. I will also inform a member of staff if any of the above 
information changes during the course of this module, such that it may affect the 
completion of any exercise testing 
 
 
 
 
Name     Signature    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-exercise activity  
1. Have you eaten within the last 2 hours? 
2. Have you drunk coffee or tea within the last 2 hours? 
3. Have you smoked within the last 12 hours? 
4. Have you consumed alcohol within the last 24 hours? 
5. Have you performed exhaustive exercise within the 
last 48 hours? 
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7.8 Exertion and Pain Rating Instructions (5km Time Trial) 
 
While exercising I want you to rate your perception of exertion, i.e., how heavy and 
strenuous the exercise feels to you. This will depend mainly on the strain and fatigue in your 
muscles and on your feeling of breathlessness or aches in your chest. Try to rate your 
feelings of exertion as honestly as possible without thinking about what the actual physical 
load is. Look at the scale and the expressions and then give a number where 6 means no 
exertion at all and 20 means maximal exertion. 
 
After rating your exertion, I will also want you to rate your perception of pain on this scale 
from no pain (0) to the worst possible pain imaginable (10). When rating these pain 
sensations, be sure to attend only to the specific sensations in your legs and not report other 
pains you may be feeling (e.g. seat discomfort). It is important that your ratings of pain 
intensity reflect only the degree of hurt you feel in your legs during exercise and not as an 
expression of fatigue. 
 
Please provide your exertion ratings first followed by pain ratings and use verbal expressions 
to help rate your perceptions which I will take every 0.5km. Both scales are provided in front 
of you on this stand for reference. Don’t underestimate or overestimate the degree of fatigue 
or hurt you feel when rating your exertion and pain ratings respectively, just try and estimate 
them as honestly and objectively as possible. Any questions? 
 
“  
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